NCT04552353View on ClinicalTrials.gov

Evaluate Bioequivalence of Voriconazole(200mg/Vial) .

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 13, 2020

Primary Completion Date

June 21, 2020

Study Completion Date

June 21, 2020

Conditions
Antimycotic for Systematic Use
Interventions
DRUG

Vaway

Drug: Voriconazole. Pharmacokinetic study under fasting conditions

Trial Locations (1)

Unknown

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT04552353 - Evaluate Bioequivalence of Voriconazole(200mg/Vial) . | Biotech Hunter | Biotech Hunter